Anti-Atherosclerotic Properties of Wild Rice in Low-Density Lipoprotein Receptor Knockout Mice: The Gut Microbiome, Cytokines, and Metabolomics Study

Abstract

Background and aim: We previously reported the anti-atherogenic properties of wild rice in low-density lipoprotein receptor knockout (LDL-r-KO) mice. The present study aimed to discover the mechanism of action for such effects. Materials: Fecal and plasma samples from the wild rice treated and control mice were used. Fecal bacterial population was estimated while using 16S rDNA technology. The plasma samples were used to estimate the levels of 35 inflammatory markers and metabolomics, while using Meso Scale multiplex assay and liquid chromatography-mass spectrometry (LC-MS/MS) techniques. Results: Many bacteria, particularly Anaeroplasma sp., Acetatifactor sp., and Prophyromonadaceae sp., were found in higher quantities in the feces of wild rice fed mice as compared to the controls. Cytokine profiles were significantly different between the plasma of treated and control mice. Among them, an increase in the level of IL-10 and erythropoietin (EPO) could explain the anti-atherogenic properties of wild rice. Among many metabolites tested in plasma of these animals, surprisingly, we found an approximately 60% increase in the levels of glucose in the wild rice fed mice as compared to that in the control mice. Conclusion: Additional studies warrant further investigation of the interplay among gut microbiome, inflammatory status, and macronutrient metabolism.

Flazin as a Lipid Droplet Regulator against Lipid Disorders

“…Dysregulation of lipid metabolism has been verified as the main cause of many metabolic diseases, including diabetic nephropathy (DN), atherosclerosis, non-alcoholic fatty liver disease, and others [ 1 , 2 , 3 , 4 ]. The prevalence of these metabolic diseases is increasing along with the global pandemic of obesity [ 5 ].…”

“…An appropriate diet is one of the major determinants of maintaining optimal health [ 2 ]. Diet-derived bioactive components also receive a long-lasting focus on their nutraceutical potential in treating metabolic diseases [ 9 , 10 ].…”

Nutraceuticals and Nutrition Supplements: Challenges and Opportunities

“…We have invited international experts, researchers and authors to submit original research and review articles that address the progress and our current understanding of nutraceuticals/supplements from in vitro and in vivo studies, as well as from clinical trials describing the benefits/adverse effects with underlying mechanisms. This Special Issue presents a compendium of excellent laboratory and clinical studies using plant extracts [ 15 , 16 , 17 , 18 , 19 , 20 ], purified compounds [ 21 , 22 , 23 ], modified formulations [ 22 , 24 ], and probiotics [ 25 , 26 , 27 , 28 ] to improve many health conditions, including metabolic disorders [ 17 , 20 ], cardiovascular disease [ 29 ], muscle metabolism [ 18 , 25 ], obesity [ 16 , 17 , 20 ], neurological disorders [ 30 ], infectious diseases [ 26 , 27 ], aging [ 23 ], and cancers [ 18 , 21 , 24 , 31 ].…”